Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
7:42
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm
Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm Similar Videos
Similar Videos
-
Expert Insights: Novel Agents and Evolving Strategies in Myeloproliferative Neoplasms – A Focus on Myelofibrosis_Srdan Verstovsek, MD, PhD_Naveen Pemmaraju, MD
23:21
-
Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD
16:54
-
Risk-Stratification and Management Strategies for MPNs_Elizabeth Hexner, MD, MSTR
18:01
